Se. Andersson et B. Almegard, CGRP(8-37) AND CGRP(32-37) CONTRACT THE IRIS SPHINCTER IN THE RABBIT EYE - ANTAGONISM BY SPANTIDE AND GR82334, Regulatory peptides, 49(1), 1993, pp. 73-80
The effects of intracameral injections of CGRP(8-37) and CGRP(32-37) o
n pupil diameter and blood-aqueous barrier have been investigated in r
abbits. The rabbits, which were pretreated with indomethacin and a mus
carinic antagonist (biperiden), responded with miosis to both CGRP fra
gments. CGRP(8-37) was much more potent than CGRP(32-37) but one order
of magnitude less potent than substance P. Nerve blockade with tetrod
otoxin did not affect the response, indicating a direct effect on the
iris sphincter muscle. Pre-treatment with the unselective tachykinin r
eceptor antagonist spantide or the NK, receptor selective antagonist G
R82334 caused a rightward shift of the dose-response curves for both f
ragments, while the CCK receptor antagonist loxiglumide had no inhibit
ory effect. Neither of the fragments induced any marked leakage of Eva
ns blue into the aqueous humor indicating that there was no agonistic
interaction with CGRP receptors in the eye. We conclude that CGRP(8-37
) and CGRP(32-37) are miotic agents in the rabbit eye, possibly by act
ing as neurokinin receptor agonists.